China Medical Device Authority Restructured as NMPA

In March 2018, China restructured the medical device authority from China Food and Drug Administration (Known as CFDA) to National Medical Products Administration(Known as NMPA), it is administered by the State Administration for Market Regulation (Known as SAMR).

The new name NMPA shall be adapted from 1st September 2018, it has been changed ‘CFDA’ to ‘NMPA’ in the medical device registration and approval system. Any registrants need to use the new name and its abbreviation of the China medical device authorities during the medical device registration in China.

Contact Us
CIRS China

Ms. Shuo Wang (Head office)
Tel: +86-571 8720 6559 | Fax: +86-571 87206533
Mr. Edwin Wen (Beijing office)
Tel: +86-10 63984062 | Fax: +86-10 63984032

CIRS Europe

Bryan Zhou
Tel:  +353 (1)477 3710


CIRS Korea
Mr. Junho Lee 
Tel: +82 2 6347 8801